Flow cytometric enumeration of micronucleated reticulocytes: high transferability among 14 laboratories
D.K. Torous1, N.E. Hall1, S.D. Dertinger1, M.S. Diehl2, A.H. Illi-Love2, K. Cederbrant3, K. Sandelin3, G. Bolcsfoldi3, L.R. Ferguson4, A. Pearson4, J.B. Majeska5, J.P. Tarca5, D.R. Hewish6, L. Doughty6, M. Fenech6, J.L. Weaver7, D.D. Broud7, D.G. Gatehouse8, G.M. Hynes8, P. Kwanyuen8, J. McLean9, J.P. McNamee9, M. Parenteau9, V. Van Hoof10, P. Vanparys10, M. Lenarczyk11, J. Siennicka11, B. Litwinska11, M.G. Slowikowska11, P.R. Harbach12, C.W. Johnson12, S. Zhao12, C.S. Aaron12, A.M. Lynch13, I.C. Marshall13, B. Rodgers14, C.R. Tometsko1
1 Litron Laboratories
2 Abbott Laboratories
3 AstraZeneca
4 Auckland Cancer Society
5 Boehringer Ingelheim Pharmaceuticals
6 CSIRO (Commonwealth Scientific and Industrial Research Organization) Health Sciences and Nutrition, 7 Food and Drug Administration/CDER (Center for Drug Evaluation and Research)
8 GlaxoWellcome
9 Health Canada
10 Janssen Pharmaceutica
11 National Institute of Hygiene
12 Pharmacia & Upjohn
13 SmithKline Beecham
14 Texas Tech University
Environmental and Molecular Mutagenesis
Volume 38, Issue 1, 2001, Pages 59–68